US 11261231
Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitors
granted A61PA61P31/12A61P31/18
Quick answer
US patent 11261231 (Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitors) held by The Regents of the University of California expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P31/12, A61P31/18, A61P37/04, A61P43/00